Skip to main content
Premium Trial:

Request an Annual Quote

GeneBio to Exclusively Distribute Proteome s Database

NEW YORK, Sept. 5 — Geneva Bioinformatics, the commercial arm of the Swiss Institute of Bioinformatics (SIB), said on Tuesday it had obtained the rights to exclusively distribute GlycoSuite, Proteome Systems’ database of protein glycosylation.

Glycosylation is a variety of protein modifications important in protein function and diseases such as cancer.

“A significant problem was that information concerning glycosylation was scattered throughout the literature in thousands of scientific publications,” said Proteome Systems CEO Keith Williams in a statement.

Hrre is some more test - with quotes How about single quotes '

“In GlycoSuiteDB, Proteome Systems has curated a large part of the scientific literature on protein glycosylation to make it available in an easily searchable form,” he said.

The database, said Williams, allows researchers to ask questions such as, “Which proteins show glycosylation changes during cancer?”

SIB maintains protein and proteomic databases, including SWISS-PROT, an annotated non-redundant sequence database in collaboration with the European Bioinformatics Institute; PROSITE, a database of protein families and domains; and SWISS-2DPAGE, a database of proteins identified on 2-D PAGE reference maps.

The databases are licensed free of charge to academic institutions. GeneBio offers commercial subscribers annual subscriptions along with proprietary protein analysis software.

GeneBio CEO Erik Baas said that adding GlycoSuite to the package “will provide researchers with unparalleled opportunities to address commercially important problems in the field of proteomics.”

Proteome Systems of Sydney, Australia is an informatics, proteomic instrument, and drug discovery company. It has strategic alliances with Dow AgroSciences, MicroFab Technologies and Shimadzu of Japan.

The Scan

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.

Study Points to Benefits of Local Consolidative Therapy, Targeted Treatments in Cancer Care

In JCO Precision Oncology, researchers report that local consolidative therapy combined with molecularly targeted treatments could improve survival for some lung cancer patients.

Genetic Variants That Lower LDL Cholesterol Linked to Reduced Heart Disease Risk

Rare variants in two genes that lower LDL cholesterol are also associated with a decreased risk of coronary heart disease, according to a new JAMA Cardiology study.

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.